We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

New WBRT Technique Reduces Neurocognitive Decline Risk

By MedImaging International staff writers
Posted on 08 Nov 2018
Print article
Adverse cognition effects of whole- brain radiotherapy (WBRT) can be significantly mitigated by using a hippocampal sparing technique and a neuroprotective agent, claims a new study.

Researchers at Northwestern Medicine Cancer Center (Warrenville, IL, USA) conducted a study in 518 adult patients with brain metastases who were stratified by analysis of prognostic factors and by whether or not they had previously undergone radiosurgery or surgical resection. The patients were randomized to a combination of memantine (a low-affinity glutamatergic antagonist) and WBRT at a dose of 30 Gy in 10 fractions, or to memantine plus WBRT and hippocampal avoidance, again at a dose of 30 Gy in 10 fractions.

The results revealed that at six months, cognitive function failure rates were 59.5% in the hippocampal avoidance arm, compared 68.2% in the control arm, a 24% reduction. Cognitive function failure curves began to separate at three months, maintained through the follow-up period. Following adjustment for treatment factors and age, the additional use of hippocampal avoidance techniques led to a 26% relative risk reduction in cognitive failure compared with WBRT plus memantine, in all age groups. The study was presented at the American Society for Radiation Oncology (ASTRO) annual conference, held during October 2018 in San Antonio (TX, USA).

“Quality of life for patients with brain metastases can be largely driven by their cognitive function, and we've come to understand that WBRT can significantly impact that cognitive function outcome as well as the quality of life associated with it,” said lead author Vinai Gondi, MD. “Conformal avoidance of the hippocampal dentate gyrus using during WBRT plus memantine preserves cognitive function in patients with brain metastases with no difference in toxicity, intracranial progression-free survival rates, or overall survival.”

The hippocampus (named after its resemblance to the seahorse) is a major component of the brains of humans and other vertebrates. The hippocampus belongs to the limbic system and plays important roles in the consolidation of information from short-term, long-term, and spatial memory. It is located under the cerebral cortex, and contains two main interlocking parts: the hippocampus proper (also called Ammon's horn) and the dentate gyrus.

Related Links:
Northwestern Medicine Cancer Center

Portable X-ray Unit
AJEX140H
Ultra-Flat DR Detector
meX+1717SCC
40/80-Slice CT System
uCT 528
New
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices

Print article

Channels

MRI

view channel
Image: The AI tool can help interpret and assess how well treatments are working for MS patients (Photo courtesy of Shutterstock)

AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans

Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more